Association of IGF-1 CA(n) and IGFBP3 rs2854746 Polymorphisms with Endometrial Polyp Risk

Table 1

Epidemiological characterization of patients with arterial hypertension, use of hormone replacement therapy (HRT), age group, diabetes, and evaluation of body mass index (BMI).

	Control	Polyp	O.R	95 C.I.	P-Value
Arterial hypertension
no	44(56%)	74(71%)
yes	35(44%)	30(29%)	0,509	(0,275 -0,941)	0,031
no answer	2	0
HRT
no	44(56%)	89(87%)
yes	34(44%)	13(13%)	0,189	(0,090 -0,393)	<0,001
no answer	3	2
Age range
29-39	3 (4%)	36(35%)
40-49	8 (10%)	22(21%)	0,229	(0,054 -0,956)	0,043
50-59	52 (65%)	18(17%)	0,028	(0,007 -0,105)	<0,001
60-80	17 (21%)	28(27%)	0,137	(0,036 -0,515)	0,003
no answer	1	0
Diabetes
no	72 (92%)	96 (92%)
yes	6 (8%)	8 (8%)	0,980
no answer	2	0
Body Mass Index
normal	30 (39%)	36(37%)
overweight	25 (33%)	35(35%)
obese	21 (28%)	27(28%)	0,912
no answer	5	6